Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples